Efavirenz (Effavirenz) — Patient-Friendly Guide

Efavirenz is an antiretroviral medicine used to treat HIV (Human Immunodeficiency Virus). It belongs to a group of medicines called NNRTIs (non-nucleoside reverse transcriptase inhibitors). Efavirenz helps reduce the amount of HIV in the body, supporting immune function and lowering the risk of HIV-related illness.

This guide is written for people in the United Kingdom and explains what efavirenz is, how it works, how it is taken, key safety information, and practical considerations—so you can make informed decisions with your healthcare team.

Quick product information

How efavirenz works (mechanism of action)

HIV relies on an enzyme called reverse transcriptase to convert its genetic material into a form that can enter human cells and begin making more virus. Efavirenz blocks this process.

• Efavirenz binds to reverse transcriptase at a specific site (the NNRTI binding pocket).
• This inhibits viral replication by preventing efficient conversion and production of new HIV particles.
• Because efavirenz targets viral replication, it is used as part of combination therapy to improve effectiveness and reduce the risk of resistance.

Important: Efavirenz does not cure HIV. With correct, consistent use, it can dramatically reduce viral load and allow the immune system to recover.

Pharmacokinetics (how the body handles efavirenz)

Understanding how the drug behaves in the body can help you take it correctly and know what to expect.

• Absorption: Efavirenz is absorbed after oral dosing. Food can affect levels, which is why instructions about meals matter.
• Peak effect: Concentrations typically rise after dosing, with measurable levels in the bloodstream.
• Distribution: Efavirenz spreads through tissues, including the central nervous system (which may explain certain side effects).
• Metabolism: It is primarily broken down in the liver, including via CYP450 enzymes (notably CYP2B6).
• Elimination: Efavirenz is removed gradually (it has a relatively long effective half-life), which supports once-daily dosing for many regimens.

Clinical implication: If you miss doses, antiviral coverage may decrease gradually rather than immediately—but missing doses can still increase the risk of viral rebound and resistance.

Typical use in the UK

Efavirenz is used in the treatment of HIV as part of combination antiretroviral therapy. Treatment plans in the UK are tailored to the individual, depending on factors such as:

• Previous HIV treatment history
• Resistance testing (if relevant)
• Co-existing medical conditions
• Other medicines you take (to avoid harmful interactions)
• Pregnancy plans or pregnancy status (special considerations apply)

In practice, efavirenz may be used in some established regimens and may also appear in older treatment options depending on clinical history and local guidance.

Indications (what efavirenz is used for)

Efavirenz is indicated for the treatment of HIV infection in combination with other antiretroviral medicines.

Efavirenz may be considered for certain adults and adolescents depending on clinical circumstances. Suitability depends on your treatment plan and the presence of any contraindications or interaction risks.

How to take efavirenz (timing and practical dosing approach)

Always follow the instructions provided by your healthcare team. Dosing regimens can vary based on your regimen, tablet strength, and personal factors.

Typical timing

• Efavirenz is commonly taken once daily.
• Because efavirenz can cause sleep-related or dizziness-type effects in some people, many regimens advise taking it at bedtime to reduce impact on daytime activities.
• If you experience side effects, your clinician may recommend how to manage them and when to take the dose.

Food guidance (important)

• Food can increase efavirenz blood levels. Higher levels may raise the risk of side effects.
• To help keep blood levels steadier, many instructions recommend taking efavirenz on an empty stomach or consistently with similar meal patterns.
• Because recommendations can differ by formulation and local practice, it’s best to follow the specific directions you receive.

Tip for routine: Choose a meal pattern you can maintain reliably (e.g., consistent timing and similar meal size), unless your healthcare team advises otherwise.

Food interactions in more detail

The biggest food-related consideration is how much and what type of food you eat around the dose.

• Large or fatty meals may increase efavirenz absorption, potentially leading to stronger CNS effects (e.g., dizziness, vivid dreams, sleep disturbance).
• Consistency matters: if you take efavirenz with meals one day and on an empty stomach the next, levels may fluctuate.

Practical approach: If you have been told to take efavirenz without food, avoid taking it immediately after a heavy meal. If you’re unsure, ask your pharmacist to review your specific directions.

Alcohol and medicine interactions

Alcohol

Efavirenz can affect the nervous system. Alcohol can also affect alertness and coordination. Together, they may make side effects like dizziness, sleepiness, or impaired concentration more noticeable.

• For safety, it’s generally sensible to limit alcohol, especially during the first weeks of treatment.
• If you plan to drink, consider whether you can safely drive or operate machinery.

Medicine interactions

Efavirenz is known to interact with many medicines because it can influence liver enzymes that metabolise drugs. This can change drug levels and lead to reduced effectiveness or increased side effects.

Examples of common interaction risk areas include:

• Other antiretrovirals (may change levels depending on which combination you use)
• Hormonal contraception (some interactions may reduce effectiveness; non-hormonal or reinforced methods may be recommended)
• Antifungals and antibiotics (some can increase or decrease efavirenz levels)
• Anti-epileptics (some seizure medicines can lower efavirenz levels)
• Medicines for tuberculosis (rifampicin/rifabutin may be relevant depending on your regimen)
• Herbal products (particularly St John’s Wort) which can reduce effectiveness

Always tell your pharmacist and healthcare team about every medicine you use—including over-the-counter products, vitamins, supplements, and herbal remedies.

Safety profile and potential side effects

Most people tolerate efavirenz reasonably well when used as part of appropriate combination therapy. However, like all medicines, it can cause side effects.

Common side effects

• CNS effects: dizziness, sleep disturbance, abnormal dreams or vivid dreams, headache
• Gastrointestinal effects: nausea, vomiting, diarrhoea
• General effects: fatigue

Pattern of onset: CNS effects are often most noticeable in the early phase of treatment and may improve as your body adjusts.

Serious but less common risks

• Severe skin reactions (seek urgent medical attention if you develop a widespread rash, blistering, or mouth sores)
• Hepatic (liver) problems: report symptoms such as yellowing of the skin/eyes, dark urine, or severe abdominal pain
• Mental health changes: new or worsening mood changes, severe anxiety, or suicidal thoughts require prompt medical advice
• Neurological symptoms: significant confusion, severe or persistent dizziness, or problems with balance should be assessed

When to seek urgent help

Contact emergency services or urgent care if you experience:

• Signs of anaphylaxis (swelling of the face/lips, difficulty breathing)
• Severe rash with fever, blistering, or eye/mouth involvement
• Confusion, fainting, or severe neurologic symptoms
• Severe allergic reactions or rapidly worsening symptoms

Practical use tips (to improve comfort and adherence)

• Take it at the same time every day. If your regimen allows, bedtime dosing may reduce daytime CNS effects.
• Keep food guidance consistent. Follow whether you should take it with food or on an empty stomach.
• Plan for early side effects. In the first few weeks, expect possible dizziness or vivid dreams and take care with driving or machinery until you know how you respond.
• Don’t stop suddenly. Stopping or missing doses can allow HIV to rebound and may increase resistance risk.
• Use a medication organiser (pill box) or mobile reminder to reduce missed doses.
• Be honest about alcohol and recreational drugs. This helps your healthcare team advise you safely about interactions and side effects.
• Report changes early. If side effects worsen or you develop new symptoms, contact your clinician promptly.

Dosing information

Dosing depends on the exact regimen and patient factors. For efavirenz, typical dosing strategies used in clinical practice include:

• Adults and adolescents: often once daily as part of combination therapy, with dose adjusted to the specific product strength and local guidance.
• Special populations: dose suitability may change with liver disease, interacting medicines, or pregnancy-related considerations.

Important: Do not adjust the dose yourself. If you think you are under- or overdosing, seek advice immediately.

Pregnancy, breastfeeding, and fertility considerations

Efavirenz may not be suitable for all pregnancy situations. HIV treatment in pregnancy is complex and must be coordinated with specialist services to protect both parent and baby.

• If you are pregnant, planning pregnancy, or could become pregnant, discuss efavirenz promptly with your healthcare team.
• Contraception may be affected by drug interactions—ask for personalised advice about the safest method while taking efavirenz.
• Breastfeeding guidance depends on local and individual recommendations; follow advice from your HIV clinic or maternity team.

Alternative options to consider

There are multiple antiretroviral options available in the UK, including other NNRTIs, integrase inhibitors, protease inhibitors, and combination single-tablet regimens. The best choice depends on your viral load, resistance history, co-medications, and personal circumstances.

Examples of alternative approaches (not exhaustive):

• Integrase inhibitors (often preferred in modern regimens due to potency and tolerability for many people)
• Other NNRTIs (may be used in certain regimens depending on suitability)
• Protease inhibitor-based therapy in selected cases

Your clinician can explain the pros and cons of switching, including how they manage interactions, side effects, and resistance risk.

UK market and legal context (how medicines are regulated)

In the UK, medicines are regulated through the Medicines and Healthcare products Regulatory Agency (MHRA), and the National Health Service (NHS) provides guidelines and pathways for HIV care. Antiretroviral prescribing and dispensing is handled through established clinical and pharmacy processes.

Available products and specific brand/formulation names can change over time. If you are sourcing efavirenz, ensure you receive a product that is appropriate for your needs and complies with UK supply rules.

Recent guidance and clinical practice trends

In recent years, HIV treatment recommendations have increasingly favoured regimens with improved tolerability and efficacy. Integrase-based combinations are commonly used as first-line treatment in many settings.

That said, efavirenz may still be relevant for certain people due to:

• Established treatment history
• Virological suppression on a current regimen
• Specific resistance patterns or clinical constraints
• Availability of alternatives and individual tolerability

Your HIV clinic can confirm whether efavirenz remains an appropriate choice for you and whether switching is recommended based on your current status.

Delivery and availability in the United Kingdom

Online pharmacies in the UK may offer delivery services for eligible medicines. Availability depends on stock levels, product strength, and supplier arrangements.

• Dispatch times: Some orders are dispatched quickly when stock is available; others may require processing time.
• Packaging: Medicines are typically supplied in secure, tamper-evident packaging.
• Delivery address: Ensure the delivery address is accurate to avoid delays.
• Storage: Follow the storage conditions on the outer carton or patient information leaflet (e.g., keep in a cool, dry place; protect from moisture unless stated otherwise).

Tip: If you need efavirenz as part of long-term therapy, ordering early can help avoid gaps between supplies.

FAQ about efavirenz

1) What is efavirenz used for?

Efavirenz is used as part of combination therapy to treat HIV infection. It helps reduce viral replication and supports immune function.

2) How quickly does efavirenz work?

Many people see a reduction in viral load within weeks, but the speed of response can vary. Your clinic will monitor viral load and safety blood tests according to your plan.

3) Should I take efavirenz with food?

Food can affect efavirenz absorption and increase blood levels. Many regimens recommend taking it on an empty stomach or with consistent dietary instructions. Follow the specific advice you were given for your product.

4) Why do people take efavirenz at night?

Efavirenz can cause dizziness, sleep disturbance, and vivid dreams in some people. Bedtime dosing may reduce the impact of these effects on daytime activities.

5) Can I drink alcohol while taking efavirenz?

Alcohol may increase dizziness or drowsiness. It’s usually best to limit alcohol and avoid driving or operating machinery if you feel affected.

6) What medicines should I avoid?

Efavirenz interacts with many medicines. Avoid or get advice before starting new medicines, including some anticonvulsants, antibiotics/antifungals, hormonal contraception, and herbal products like St John’s Wort.

7) What if I miss a dose?

Take the missed dose as soon as you remember if it’s close to the time you usually take it, unless your healthcare team advises otherwise. If you’re close to the next dose, skip the missed dose—do not double up. If unsure, ask your pharmacist or clinic for personalised instructions.

8) What side effects should concern me?

Seek urgent medical help for severe rash, blistering, breathing difficulties, or signs of serious liver problems. Contact your clinician promptly for worsening mood changes, severe dizziness, or severe neurologic symptoms.

9) Can I stop efavirenz if I feel better?

No. Even if you feel well, HIV can continue replicating if treatment stops. Stopping can lead to viral rebound and resistance. Any changes should be discussed with your HIV team.

10) Are there alternatives if efavirenz doesn’t suit me?

Yes. There are other antiretroviral options available in the UK. Your clinician can recommend an alternative based on your treatment history, resistance profile, and tolerability.

Disclaimer: This information is intended to help you understand efavirenz. It does not replace advice from a qualified healthcare professional. If you have questions about your specific regimen, side effects, or interactions, speak to your pharmacist or HIV clinic.